Replies to post #17389 on RespireRx Pharmaceuticals Inc (RSPI)

[atheroprevent]

I agree, haysaw, Cor is a longshot, but all biotech is highrisk. No capitalized pharmaceutical with squander assets until POC is validated, hence the .3 R+R. Buyout of unvalidated intellectual property would be like giving major league contracts to little league players prepuberty.

I and others far more expert do think the odds favor RD outcome with at least a positive signal coming from the German studies.

Then let the games begin!

PS Gfp, barbiturates were one of the first drugs used for treatment of seizures. Narcotics are probably neutral with regard to seizures, unless you are in a withdrawal state, where it may be seizure provoking.